Archive: 2026/06

How the FDA Ensures Generic Drugs Work the Same as Brand-Name Medications
10 June 2026 0 Comments Gregory Ashwell

How the FDA Ensures Generic Drugs Work the Same as Brand-Name Medications

Discover how the FDA guarantees generic drugs match brand-name efficacy through bioequivalence testing, the ANDA process, and strict manufacturing standards under the Hatch-Waxman Act.

Statins and Exercise-Induced Muscle Injury: Prevention Tips
8 June 2026 0 Comments Gregory Ashwell

Statins and Exercise-Induced Muscle Injury: Prevention Tips

Learn how to safely exercise while taking statins. Discover prevention tips for muscle pain, the difference between moderate and vigorous activity, and which statins are gentlest on your muscles.

Citalopram vs Escitalopram: Understanding QT Prolongation Risks and Safe Dose Limits
5 June 2026 0 Comments Gregory Ashwell

Citalopram vs Escitalopram: Understanding QT Prolongation Risks and Safe Dose Limits

Explore the QT prolongation risks of Citalopram and Escitalopram. Learn about dose limits, regulatory warnings, and how to manage cardiac safety while treating depression.

How to Confirm Pharmacist Notes and Counseling Points After Pickup: A Step-by-Step Guide
3 June 2026 8 Comments Gregory Ashwell

How to Confirm Pharmacist Notes and Counseling Points After Pickup: A Step-by-Step Guide

Learn how to verify pharmacist counseling notes after pickup to prevent medication errors. This guide covers accessing digital records from CVS, Walgreens, and independents, plus tips for securing written documentation.

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval
1 June 2026 0 Comments Gregory Ashwell

Post-Market Surveillance: How the FDA Monitors Generic Drugs After Approval

Discover how the FDA monitors generic drug safety after approval using FAERS, the Sentinel Initiative, and AI. Learn about post-market surveillance, complex generics, and what happens when safety signals emerge.